Biotech Values

[turtlepower]

Are you of the expectation that just the announcement that they plan to file for accelerate approval, if that is indeed what they announce, will cause a jump in the share price or do you expect it would take an actual ultimate decision to move the stock?

I think if the EMA accepted the filing it would give investors some confidence in the PRECEDENT data and in a positive outcome in the PROCEED trial. I'm not sure whether the share price will jump significantly or not but right now the EV is close to zero so hopefully that will change in the positive direction after next tuesday.

Endocyte didn't publicly announce it until monday but it looks like they were granted orphan status in early february and while that in itself may not be a big deal the EMA appears to think that Endocyte has provide "sufficient information to show that this medicine may be of significant benefit for patients with ovarian cancer".

http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_designation/2012/02/WC500123293.pdf
http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_designation/2012/02/WC500123294.pdf